• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Keywords » smoking_cessation_agents

Items Tagged with 'smoking_cessation_agents'

ARTICLES

smoking.jpeg

How to Use Varenicline (Chantix)

May 1, 2022
Stephen Wyatt, DO.
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Steven A. Wyatt, DO. Adjunct faculty, University of North Carolina at Charlotte. Dr. Wyatt has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

There are three medications with FDA approval for nicotine dependence: Nicotine replacement therapies, bupropion, and varenicline. Varenicline (Chantix) is arguably the most effective, but cost and concerns about neuropsychiatric side effects have limited its use, and a recent recall of the product temporarily stopped it entirely.
Read More

Using Smoking Cessation Medications in Patients With Mental Illness

January 18, 2022
Michael Weaver, MD, FASAM.
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Michael Weaver, MD, FASAM. Professor and medical director at the Center for Neurobehavioral Research on Addictions at the University of Texas Medical School. Dr. Weaver has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Helping patients with mental illness quit smoking can be particularly challenging; however, there are evidenced based strategies that can help. In this article, we review the evidence for smoking cessation medications in patients with mental illness and highlight some important special considerations.
Read More

Varenicline and Bupropion: Soaring Again With EAGLES?

November 22, 2019
Nicholas Rosenlicht, MD.
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Nicholas Rosenlicht, MD. Dr. Rosenlicht has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
This research update unpacks the details behind the landmark “EAGLES” trial (Evaluating Adverse Events in a Global Smoking Cessation Study), which led to the removal of the varenicline black box warning.
Read More

Smoking Cessation and Psychiatric Disorders

March 1, 2018
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Over the last few decades, doctors have done a better job at convincing their patients to stop smoking. But much of this improvement has been relegated to patients without mental illness.
Read More
RESEARCH UPDATE

Good News for Smoking Cessation Drugs: Not as Scary as Once Thought

June 1, 2016
Bret A. Moore, PsyD, ABPP
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Bret A. Moore, PsyD, ABPP                                    

Board-Certified Clinical Psychologist, San Antonio, TX.                                       

Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Both varenicline (Chantix) and bupropion (Zyban) are effective anti-smoking agents, but over the years we’ve heard about potential neuropsychiatric side effects, especially related to varenicline. These include depression, suicidal thoughts, psychosis, and nightmares.
Read More

How to Treat Tobacco Use Disorder—A Primer

June 1, 2015
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Daniel Carlat, MD
You may or may not consider smoking cessation to be part of your job description. But tobacco use disorder is a psychiatric syndrome, per DSM-5.
Read More

Understanding the New World of E-Cigarettes

June 1, 2015
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Dr. Eissenberg discusses e-cigarettes, including an overview of the product, ways they are used and misused, and how they fit into the landscape of smoking cessation methods.
Read More

It Pays to Quit Smoking

June 1, 2015
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Quitting smoking requires a lot of motivation—something our patients don’t always have. Since money is a great motivator, various programs that pay patients to quit have been tried over the years. But how well does this technique work?
Read More

Do Electronic Cigarettes Help Smokers Quit?

April 1, 2015
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
More and more smokers are trying out electronic cigarettes (e-cigarettes) in the hopes of quitting smoking. Is this an effective tool for smoking cessation and should you be recommending it to patients?
Read More

FDA Warns About Combining Chantix and Alcohol

April 1, 2015
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
The anti-smoking drug Chantix (varenicline) may affect how people respond to alcohol, according to an FDA warning.
Read More
More Articles Tagged with 'smoking_cessation_agents'
Introducing Carlat Total Access Subscriptions

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • CMFB2e_Cover.png

    (PRE-ORDER) Child Medication Fact Book for Psychiatric Practice, Second Edition (2023)

    All the important facts covering child and adolescent psychopharmacology.
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto11543850.jpg
    General Psychiatry

    Elvis, Adderall, and a Broken Heart - Part 1

    A new medical investigation changes our understanding of Elvis Presley’s untimely death and offer some pearls for modern psychiatric practice.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.